Table 4

Overview of the cardiovascular risk scores, that have been quantified for their impact on treatment and cardiovascular complications, and that are incorporated in national/clinical guidelines

ReferenceImpact studiesGuidelines
Stevens 2001 (UKPDS risk engine)23NICE,4 CDA,19 AU,20 IDF21
Decode study Group 200452EASD3
Wilson 1998 (Framingham)62EASD3
Anderson 1991 (Framingham)65 66Two studies: change in medication78 80One study: no change79JBS2,5 AU20
  • AU, Australian National Vascular Disease Prevention Alliance; CDA, Canadian Diabetes Association; EASD, European Society of Cardiology and European Association for Study of Diabetes Guidelines; IDF, International Diabetes Federation; JBS2, Joint British Society; NICE, National Institute for Health and Clinical Excellence.